Replies to post #222036 on Biotech Values

[DewDiligence]

Correct—I will repost. (The $353M figure was the cash balance at 12/31/17, not 9/30/18.) Thanks for noticing!

p.s. Did you listen to the CC?

[DewDiligence]

ghmm et al re NKTR—Do you know why the phase-3 melanoma trial of Opdivo ± NKTR-214 is open label?

https://www.clinicaltrials.gov/ct2/show/NCT03635983